Scrutiny Continues to Grow Around the Cost of Specialty Drugs

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.